Zobrazeno 1 - 4
of 4
pro vyhledávání: '"du Bois, A"'
Autor:
Anett Kahl, Sebastian Heikaus, Florian Heitz, Stephanie Schneider, Philipp Harter, Beyhan Ataseven, Christoph Grimm, Christian Kurzeder, Alexander Traut, Sonia Prader, Andreas du Bois
Publikováno v:
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 26(9)
ObjectiveEpithelial ovarian cancer (EOC) patients with the presence of abdominal wall metastasis (AWM) are categorized as stage International Federation of Gynecology and Obstetrics (FIGO) IVB, irrespective of other biologic factors or preceding inva
Autor:
Nadeem Siddiqui, Jacobus Pfisterer, Michael A. Bookman, Ann Marie Swart, Andreas du Bois, Amit M. Oza, Mark F. Brady, Nicoletta Colombo, Eric Pujade-Lauraine, Alexander Reuss, Helen Mackay
Publikováno v:
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 20(6)
Background:The prognostic relevance of uncommon epithelial ovarian cancer (EOC) histological subtypes remains controversial. The Gynecologic Cancer InterGroup (GCIG) initiated this meta-analysis to assess the relative prognosis of women with a diagno
Autor:
Alexander Traut, Andreas du Bois, Hans-Joachim Lück, Stefan Kommoss, Philipp Harter, R. Gomez, M. Kandel
Publikováno v:
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 19(7)
Background: Carboplatinum-based retreatment can be regarded as a standard option in the so-called platinum-sensitive ovarian cancer, but its use can be limited by the occurrence of sometimes severe hypersensitivity reactions (HSRs). This study analyz
Publikováno v:
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 15(2)
The purpose of this study was to evaluate the pattern and quality of care for ovarian cancer in Germany and analyze prognostic factors with emphasis on characteristics of treating institutions, hospital volume, and participation in clinical trials. T